People · Operator
Named in public records as an officer, director or promoter · active 2024–2024 · Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| XII Medical, Inc. | — | Healthtech | Series B | $45.1M | $146.1M | 2024 |
Saoussen Ben Halima at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Saoussen Ben Halima on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Duke Rohlen | 1 | 10 |
| Aftab Kherani | 1 | 9 |
| Benjamin Pless | 1 | 5 |
| Tony Natale | 1 | 5 |
| Samuel Lee | 1 | 4 |
| Josh Nickols | 1 | 3 |
| Akhil Saklecha | 1 | 3 |
| Shane Kreidel | 1 | 2 |
| JOSEPH RICH | 1 | 2 |
| Daniel Gottlieb | 1 | 2 |
| Zachary Eisen | 1 | 1 |
| Raman Gowri | 1 | 1 |
| Garrett Schwab | 1 | 1 |
| JD Friedland | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.